ACE2 and COVID-19: Additionally, NOX activation reduces the bioavailability of nitric oxide (NO), leading to vasoconstriction, inflammation, redox imbalance, and endothelial dysfunction [172,187] in such a way that the classic RAAS, particularly the ACE2-Ang-(1–7) axis, becomes a powerful pro-oxidant system in COVID-19.